Geneos Wealth Management’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20
Closed -$1.69K 2074
2022
Q4
$1.69K Hold
20
﹤0.01% 1906
2022
Q3
$1K Sell
20
-15,816
-100% -$1.36M ﹤0.01% 1939
2022
Q2
$1.27M Hold
15,836
0.06% 273
2022
Q1
$1.52M Buy
15,836
+22
+0.1% +$2.11K 0.07% 264
2021
Q4
$1.67M Buy
15,814
+74
+0.5% +$7.71K 0.06% 280
2021
Q3
$1.56M Hold
15,740
0.06% 288
2021
Q2
$1.58M Hold
15,740
0.06% 270
2021
Q1
$1.59M Hold
15,740
0.04% 322
2020
Q4
$1.53M Buy
+15,740
New +$1.31M 0.06% 270

Other funds holding IVOG

Geneos Wealth Management's IVOG Position: Q1 2023 in Review

Geneos Wealth Management sold out of Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) in Q1 2023, closing a stake of 20 shares — an estimated $1.69K sold.

Geneos Wealth Management first reported a position in IVOG in Q4 2020 and held it in 9 quarters. The position peaked at $1.67M in Q4 2021. 98 funds tracked by Wall St. Rank hold IVOG as of Q1 2023.

  • Geneos Wealth Management reported no remaining Vanguard S&P Mid-Cap 400 Growth ETF position as of Q1 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 20 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q1 2023, an estimated $1.69K.
  • Geneos Wealth Management first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q4 2020 and held it in 9 quarters.
  • Geneos Wealth Management's Vanguard S&P Mid-Cap 400 Growth ETF position peaked at $1.67M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q1 2023.

Based on Geneos Wealth Management's 13F filing for Q1 2023, filed 25 Apr 2023.